Evidence map›Paper›PMID 42371259›Full record

ArticleCerebellum (London, England)2026

Phenotype and Genetics of Spinocerebellar Ataxia Type 27B: Novel Movement-disorder Features, Cognitive Impairment, and Repeat Expansion Findings.

Ronak Rashedi, Franca Peemöller, Hannes Erdmann, Mathias Gelderblom, Ute Hidding, Christos Ganos, Robert Chen, Angela Abicht, Simone Zittel

Abstract read
In one paragraph

Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ronak RashediDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany.
Franca PeemöllerDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany.
Hannes ErdmannMedical Genetics Center (MGZ) Munich, Munich, 80335, Germany.
Mathias GelderblomDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany.
Ute HiddingDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany.
Christos GanosEdmond J. Safra Program in Parkinson's Disease, Division of Neurology, Movement Disorder Clinic, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada.
Robert ChenEdmond J. Safra Program in Parkinson's Disease, Division of Neurology, Movement Disorder Clinic, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada.
Angela AbichtMedical Genetics Center (MGZ) Munich, Munich, 80335, Germany.
Simone ZittelDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany. s.zittel-dirks@uke.de.ORCID http://orcid.org/0000-0002-3767-6376

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinocerebellar ataxia type 27B is a recently described autosomal dominant, late-onset cerebellar ataxia caused by an intronic GAA repeat expansion in the fibroblast growth factor 14 (FGF14) gene. Despite being recognized as a frequent adult-onset ataxia, its full clinical spectrum remains incompletely understood. To characterize the neurological, cognitive, and paraclinical phenotype of patients with heterozygous FGF14 repeat expansions (>200) and expand the currently known motor and non-motor features, as well as to assess the co-occurrence of other repeat expansions. In this cross-sectional single-center study, patients with heterozygous FGF14 repeat expansions underwent standardized neurological examination and cognitive screening. Paraclinical data were reviewed when available. 18 patients were included in the study (mean age at onset: 64 [37-79], at examination: 76 [61-94]). They all presented with gait ataxia, most commonly a lateral veering gait with corrective sidesteps. In addition to the core known cerebellar phenotype, we identified other movement-disorder manifestations, including myokymia, myoclonus, dystonia, and parkinsonism, with nigrostriatal degeneration confirmed in one patient. Cognitive impairment was common, with two-thirds of patients fulfilling criteria for cerebellar cognitive-affective syndrome (mean MoCA: 25 [21-29], CCAS: 86.9/120 [62-108]). Worse CCAS and MoCA performance was associated with increasing ataxia severity. FGF14 repeat expansions ranged from 210 to 520, and co-occurrence with heterozygous expansions in RFC1 or ATXN8/ATXN8OS were identified in three patients. Earlier diagnostic misclassification as transient ischemic attack was reported in 33%. These findings expand the known phenotype of spinocerebellar ataxia type 27B, emphasizing it as a multisystem movement disorder.

Indexed as

Cognitive DysfunctionFibroblast Growth FactorsMovement DisordersSpinocerebellar AtaxiasSpinocerebellar DegenerationsAdultAgedAged, 80 and overCross-Sectional StudiesDNA Repeat ExpansionFemaleHumansMaleMiddle AgedPhenotypeTrinucleotide Repeat Expansionfibroblast growth factor 14Fibroblast Growth FactorsCerebellar Cognitive Affective SyndromeRepeat Expansion DisordersSpinocerebellar Ataxia

Identifiers

PMID42371259
PMCPMC13315097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.